Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modification of cellular membrane functions by pendolmycin.

K Umezawa1, M Imoto, T Yamashita

  • 1Institute of Microbial Chemistry, Tokyo.

Japanese Journal of Cancer Research : Gann
|January 1, 1989
PubMed
Summary

Pendolmycin, a novel indole alkaloid, effectively inhibits phosphatidylinositol turnover and modifies cell membrane functions. It demonstrates potency comparable to known tumor promoters, offering a simpler structure for potential research applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2020
Same author

Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis.

Bone marrow transplantation·2016
Same author

Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.

Oncogene·2016
Same author

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.

British journal of cancer·2014
Same author

The role of inflammatory chemokines in lymphoid neoorganogenesis in breast cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2013
Same author

Inhibition of NF- κ B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ -Radiation Cytotoxicity in Glioblastoma Cells.

Chemotherapy research and practice·2013

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Pendolmycin is a newly identified indole alkaloid derived from Nocardiopsis.
  • Its chemical structure bears resemblance to known compounds like teleocidin B and lyngbyatoxin A.

Purpose of the Study:

  • To investigate the biological activity of pendolmycin, specifically its effects on phosphatidylinositol turnover and cell membrane functions.
  • To compare the potency of pendolmycin with established tumor promoters such as teleocidin B and phorbol esters.

Main Methods:

  • Assessing the inhibition of phosphatidylinositol turnover in A431 cells by pendolmycin, teleocidin B, and 12-O-tetradecanoylphorbol-13-acetate.
  • Evaluating pendolmycin's effects on epidermal growth factor binding, arachidonic acid release, hexose transport, and phorbol-12,13-dibutylate binding in C3H10T1/2 cells.

Related Experiment Videos

Main Results:

  • Pendolmycin, teleocidin B, and 12-O-tetradecanoylphorbol-13-acetate all demonstrated inhibition of phosphatidylinositol turnover.
  • Pendolmycin was found to inhibit epidermal growth factor binding, stimulate arachidonic acid release and hexose transport, and inhibit phorbol-12,13-dibutylate binding.
  • These effects indicate pendolmycin's potent modification of cell membrane functions.

Conclusions:

  • Pendolmycin exhibits significant biological activity, impacting key cell membrane signaling pathways.
  • Its potency in modifying cell membrane functions is comparable to that of teleocidin B and phorbol ester tumor promoters.
  • Pendolmycin represents a structurally simpler compound with potent biological effects, suggesting its potential as a valuable research tool.